ATRA vs IDXX · rev $1.1M vs P/E 40, rev $2.36B
Atara Biotherapeutics Inc (ATRA) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ATRA currently screens at market cap $87.1M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ATRA and IDXX stock pages for the full models.
Not investment advice.